Holen Sie sich die Stockscreener-App
7.40
1.46%
-0.11
Neuraxis Inc Aktie (NRXS) Neueste Nachrichten
Insider Trends: Does NeurAxis Inc have pricing power2026 Levels & Technical Confirmation Alerts - baoquankhu1.vn
Treasury Yields: Should I trade or invest in NeurAxis Inc2026 Pullbacks & Capital Efficiency Focused Ideas - baoquankhu1.vn
NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth - TradingView
NeurAxis Shares Rise After Q4 Results Driven by Robust Revenue Expansion - Bitget
If You Invested $1,000 in Neuraxis Inc (NRXS) - Stock Titan
Craig Hallum Increases NeurAxis (NASDAQ:NRXS) Price Target to $13.00 - Defense World
Dip Buying: Can NeurAxis Inc outperform under higher oil prices2026 Trading Recap & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Gainers Report: Can NeurAxis Inc expand its profit marginsEarnings Beat & AI Powered Market Entry Ideas - baoquankhu1.vn
Neuraxis, Inc.: Fundamental Analysis and Financial Ratings | NRXS | US64134X2018 - marketscreener.com
NeurAxis (NASDAQ:NRXS) Given New $13.00 Price Target at Craig Hallum - MarketBeat
NeurAxis Earnings Call: Reimbursement Wins Drive Next Phase - TipRanks
Earnings call transcript: NeurAxis Q4 2025 sees revenue growth, stock dips - Investing.com Australia
NeurAxis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
NeurAxis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
NRXS: FY2025 revenue rose 33% to $3.6M, with improved net loss and expanded market access - TradingView
NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results - Bluefield Daily Telegraph
Neuraxis 10-K: $3.57M Revenue, $(7.80)M Net Loss - TradingView
NeurAxis says its pain-treatment device now reaches 100M insured lives - Stock Titan
Neuraxis (NRXS) expands IB-Stim GI neuromodulation, RED constipation device and IP moat - Stock Titan
Levels Update: Should I trade or invest in NeurAxis Inc2026 Top Gainers & Expert Curated Trade Ideas - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: NeurAxis, Inc. (NRXS), Argenx Se (ARGX) and Teladoc (TDOC) - The Globe and Mail
Aug Ideas: What is the implied volatility of NeurAxis Inc2026 Fed Impact & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
NeurAxis, Inc. Hits New 52-Week High of $7.46, Up 141.44% - Markets Mojo
Breakout Zone: Is NeurAxis Inc impacted by rising ratesTrade Exit Report & Stock Portfolio Risk Control - baoquankhu1.vn
NeurAxis, Inc. Hits New 52-Week High at USD 7.34 - Markets Mojo
Neuraxis price target raised to $8 from $7 at Craig-Hallum - MSN
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026 - Sahm
Medical tech firm NeurAxis schedules March 19 call on 2025 results - Stock Titan
Stock List: Research Stocks from Around the World - GuruFocus
NeurAxis (NASDAQ:NRXS) Shares Up 0.7%Still a Buy? - MarketBeat
NeurAxis, Inc. Hits New 52-Week High of $6.35, Up 98.97% - Markets Mojo
Volume Recap: Can TTWO expand its profit marginsJuly 2025 Action & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
How FlexShares iBoxx 3 Year Target stock trades in high volatilityMarket Activity Summary & Reliable Price Breakout Signals - Naître et grandir
Update Recap: Should you avoid OSCR stock right now2025 Macro Impact & Entry Point Confirmation Alerts - baoquankhu1.vn
Aug Highlights: Can NeurAxis Inc stock outperform in a bear marketJuly 2025 Final Week & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Chronic Idiopathic Constipation Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | ABBVIE, Eisai Co, Anji Pharma, Yuhan, Renexxion Ireland - Barchart.com
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
00152 Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
NeurAxis, Inc. Hits New 52-Week High of $6.30, Up 115.75% - Markets Mojo
S32 Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
BPCF Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
NRXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Neuraxis (NRXS) awards 47,569 RSUs to senior executive Miranda - Stock Titan
P 500Share Buyback & Expert Approved Trade Ideas - mfd.ru
NRXS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Director at Neuraxis (NRXS) receives 21,598-share equity grant as compensation - Stock Titan
Neuraxis (NRXS) CEO granted 94,173 RSUs in three-year vesting award - Stock Titan
Director at Neuraxis (NRXS) receives 21,598-share stock grant as compensation - Stock Titan
SMN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
LINK Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Volume Report: Can NeurAxis Inc stock outperform in a bear marketGap Down & Accurate Trade Setup Notifications - baoquankhu1.vn
NRXSNeuraxis Inc Latest Stock News & Market Updates - Stock Titan
Is NeurAxis Inc. impacted by rising rates2025 Price Momentum & Free Expert Verified Stock Movement Alerts - mfd.ru
Is NeurAxis Inc. in a consolidation phaseJuly 2025 Closing Moves & Reliable Price Breakout Signals - mfd.ru
What is the earnings history of Nuwellis Inc.2025 Pullback Review & Weekly Return Optimization Alerts - mfd.ru
Why MicroCloud Hologram Inc. stock attracts global investorsJuly 2025 PostEarnings & Intraday High Probability Setup Alerts - mfd.ru
Why Neuraxis Inc. stock could outperform next yearWeekly Gains Report & Free Community Supported Trade Ideas - mfd.ru
Institution Moves: Can NeurAxis Inc reach all time highs this yearWeekly Volume Report & Risk Managed Investment Signals - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: NeurAxis, Inc. (NRXS), Janux Therapeutics Inc (JANX) and BioLife Solutions (BLFS) - The Globe and Mail
09999 Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Aug Outlook: What is the cash position of PSAPRF2025 Bull vs Bear & Safe Entry Momentum Tips - baoquankhu1.vn
0.99%
3.03%
Kapitalisierung:
|
Volumen (24h):